Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1701-1706

  Wang, Guannan ^a   Xu, Zhiliang ^a   Wang, Changhua ^b   Yao, Feng ^a   Li, Juanjuan ^a   Chen, Chuang ^a   Sun, Shengrong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Breast cancer; Glycolysis; Phosphofructokinase 1

Indexed keywords

6 PHOSPHOFRUCTOKINASE; BETA ACTIN; HEXOKINASE; LACTATE DEHYDROGENASE; LACTIC ACID; PYRUVATE KINASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GLYCOLYSIS; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84886779564     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1599     Document Type: Article

References (26)

1. Szutowicz A, Kwiatkowski J and Angielski S: Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast. Br J Cancer 39: 681-687, 1979.
2. Hennipman A, Smits J, van Oirschot B, van Houwelingen JC, Rijksen G, Neyt JP, Van Unnik JA and Staal GE: Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol 8: 251-263, 1987.
3. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
4. Drake B and Cook GJ: Positron emission tomography computed tomography in oncology. Br J Hosp Med (Lond) 72: 631-637, 2011.
5. Robey IF, Stephen RM, Brown KS, Baggett BK, Gatenby RA and Gillies RJ: Regulation of the Warburg effect in early-passage breast cancer cells. Neoplasia 10: 745-756, 2008.
6. Gottlieb E and Tomlinson IP: Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5: 857-866, 2005.
7. Guppy M, Leedman P, Zu X and Russell V: Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 364: 309-315, 2002.
8. Dalgard CL, Lu H, Mohyeldin A and Verma A: Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem J 380: 419-424, 2004.
9. Papandreou I, Cairns RA, Fontana L, Lim AL and Denko NC: HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197, 2006.
10. Macheda ML, Rogers S and Best JD: Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202: 654-662, 2005.
11. El-Bacha T, de Freitas MS and Sola-Penna M: Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. Mol Genet Metab 79: 294-299, 2003.
12. Vora S, Halper JP and Knowles DM: Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation-and progression-linked discriminants of malignancy. Cancer Res 45: 2993-3001, 1985.
13. Dunaway GA: A review of animal phosphofructokinase isozymes with an emphasis on their physiological role. Mol Cell Biochem 52: 75-91, 1983.
14. Zancan P, Sola-Penna M, Furtado CM and Da Silva D: Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol Genet Metab 100: 372-378, 2010.
15. Šmerc A, Sodja E and Legiša M: Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism. PLoS One 6: e19645, 2011.
16. Shonk CE and Boxer GE: Enzyme patterns in human tissues. I. Methods for the determination of glycolytic enzymes. Cancer Res 24: 709-721, 1964.
17. Coelho WS, Costa KC and Sola-Penna M: Serotonin stimulates mouse skeletal muscle 6-phosphofructo-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization. Mol Genet Metab 92: 364-370, 2007.
18. Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004.
19. Hennipman A, van Oirschot BA, Smits J, Rijksen G and Staal GE: Glycolytic enzyme activities in breast cancer metastases. Tumour Biol 9: 241-248, 1988.
20. Hennipman A, van Oirschot BA, Smits J, Rijksen G and Staal GE: Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer. Tumour Biol 9: 178-189, 1988.
21. Hron WT and Menahan LA: Age-related changes in activities of hepatic phosphofructokinase, pyruvate kinase and pyruvate dehydrogenase in liver and adipose tissue of the swiss albino mouse. Enzyme 30: 83-88, 1983.
22. Steffen V, Gordillo E, Castano A, Caño J and Machado A: Age-dependent changes in the activity and isoenzymatic pattern of the phosphofructokinase in different areas of the central nervous systems. Neurosci Lett 125: 15-18, 1991.
23. Jia SS and Liu YH: Effects of estrogen on the expression of phosphofructokinase muscle-specific isoform in genioglossus of chronic intermittent hypoxia rats. Zhonghua Kou Qiang Yi Xue Za Zhi 45: 627-630, 2010 (In Chinese).
24. Augoff K and Grabowski K: Significance of lactate dehydrogenase measurements in diagnosis of malignancies. Pol Merkur Lekarski 17: 644-647, 2004 (In Polish).
25. Sánchez-Martínez C and Aragon JJ: Analysis of phosphofructokinase subunits and isozymes in ascites tumor cells and its original tissue, murine mammary gland. FEBS Lett 409: 86-90, 1997.
26. Moon JS, Kim HE, Koh E, Park SH, Jin WJ, Park BW, Park SW and Kim KS: Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer. J Biol Chem 286: 23808-23816, 2011.